맘모그래피 워크스테이션 시장 예측(-2034년) : 제품, 모달리티, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Mammography Workstation Market is accounted for $19.93 million in 2026 and is expected to reach $39.71 million by 2034 growing at a CAGR of 9.0% during the forecast period. The mammography workstation market refers to the sector within the healthcare industry that focuses on the development, manufacturing, and distribution of specialized computerized workstations designed for the interpretation and analysis of mammographic images. These workstations provide radiologists and healthcare professionals with a comprehensive platform to view, manipulate, and evaluate mammograms with precision.

According to the WHO, there were more than 0.6 million women dying from breast cancer in 2018, accounting for approximately 15% of all cancer deaths. According to Breast Cancer Surveillance Consortium, breast cancer detection due to mammography rose to 34.7 per 100 examinations.

Market Dynamics:

Driver:

Increasing incidence of breast cancer

With a rising global burden of breast cancer cases, there is an amplified demand for advanced diagnostic tools to facilitate early detection and precise diagnosis. Mammography workstations play a pivotal role in this scenario by providing healthcare professionals with sophisticated imaging capabilities, aiding in the identification and assessment of breast abnormalities. As breast cancer remains a leading cause of cancer-related mortality among women, the imperative for early detection has intensified.

Restraint:

High cost of equipment

The substantial initial investment required for acquiring mammography workstations, coupled with ongoing expenses for maintenance, upgrades, and software licensing, poses financial challenges for healthcare institutions. This cost burden is particularly significant for facilities in resource-constrained environments, limiting their capacity to invest in advanced diagnostic technologies. The financial implications extend to patients as well, potentially hindering accessibility to mammography services. In an era where healthcare cost containment is a priority, the expense associated with mammography workstations can slow down the widespread adoption of these advanced diagnostic tools.

Opportunity:

Growing demand for digital mammography

As healthcare systems globally transition from traditional analog to digital mammography, there is a heightened need for advanced workstations capable of handling and interpreting digital imaging data. Digital mammography offers numerous advantages, including improved image quality, reduced radiation exposure, and enhanced storage and retrieval capabilities. Mammography workstations play a crucial role in facilitating the interpretation of digital mammograms, providing radiologists with sophisticated tools for accurate diagnosis and analysis.

Threat:

Limited availability in developing regions

Access to advanced diagnostic technologies is often constrained in these areas due to factors such as limited healthcare infrastructure, financial constraints, and insufficient resources. Mammography workstations play a crucial role in early breast cancer detection, and the lack of their widespread availability in developing regions can lead to disparities in breast healthcare. However, this limitation hampers the standardization of breast cancer screening protocols and impedes efforts to improve diagnostic accuracy and patient outcomes.

Covid-19 Impact:

The disruption caused by the pandemic, including lockdowns and restrictions on non-essential healthcare services, led to a decline in routine screenings and elective medical procedures, affecting the demand for mammography workstations. Delayed or deferred mammography examinations due to the pandemic contributed to a temporary reduction in market growth. However, the awareness of the importance of early cancer detection has been heightened, emphasizing the critical role of mammography workstations in breast cancer screening. The increased focus on healthcare preparedness and the need for robust diagnostic infrastructure may drive investments in advanced mammography technologies in the post-pandemic period.

The standalone workstations segment is expected to be the largest during the forecast period

Standalone Workstations segment is expected to be the largest during the forecast period due to its autonomy and specialized functionality. These standalone workstations offer dedicated and independent solutions for mammography image interpretation, providing radiologists with an exclusive environment to analyze and diagnose breast images efficiently. Furthermore, the trend towards digital mammography has further propelled the demand for standalone workstations, as they accommodate the advanced imaging technologies and high-resolution displays necessary for accurate diagnostics.

The digital mammography segment is expected to have the highest CAGR during the forecast period

Digital Mammography segment is expected to have the highest CAGR during the forecast period with its advanced imaging capabilities and the paradigm shift from analog to digital technologies. Digital mammography offers superior image quality, enhanced resolution, and efficient storage, promoting precise breast cancer detection. The demand for corresponding mammography workstations is surging as these systems facilitate the interpretation and analysis of digital mammograms. Moreover, mammography workstations dedicated to digital images incorporate sophisticated features such as computer-aided detection (CAD) algorithms, enabling radiologists to identify subtle abnormalities with heightened accuracy.

Region with largest share:

Asia Pacific region commanded the largest share over the forecast period due to rapid technological advancements, increasing awareness of breast cancer, and a growing emphasis on healthcare infrastructure development. Countries in the region are experiencing a demographic shift, with a rising aging population, contributing to an increased prevalence of breast cancer. Governments and healthcare organizations are responding by investing in advanced mammography workstations to enhance early detection capabilities.

Region with highest CAGR:

Asia Pacific region is projected to witness profitable growth over the forecast period. Stringent guidelines and regulations set by governments to improve healthcare infrastructure and enhance early breast cancer detection are driving the demand for advanced mammography workstations. Many countries in the region are implementing screening programs and allocating substantial budgets for breast cancer awareness and diagnosis, encouraging the adoption of cutting-edge technologies. Additionally, regulatory initiatives and compliance standards are creating a favorable environment for healthcare providers to invest in state-of-the-art mammography workstations that adhere to quality and safety standards.

Key players in the market

Some of the key players in Mammography Workstation market include Agfa-Gevaert NV, Analogic Corporation, Delphinus Medical Technologies, Inc, GE Healthcare, Hologic, Konica Minolta Business Solutions India Private Limited, Medtronic, Micrima Limited, Philips Healthcare, Planmed Oy and Siemens Healthcare.

Key Developments:

In February 2022, Hologic Inc. announced the acquisition of Biotheranostics, a company that specializes in molecular diagnostic tests for breast and metastatic cancers. The acquisition is expected to strengthen Hologic's product portfolio in breast cancer diagnosis and treatment.

In January 2022, Fujifilm Holdings Corporation announced the launch of the AMULET X workstation, a new mammography workstation that offers improved diagnostic accuracy and patient comfort. The workstation is equipped with Fujifilm's proprietary digital mammography technology, which provides high-quality images with low radiation doses.

Products Covered:

• Standalone Workstations
• Integrated Workstations
• Computer-Aided Detection (CAD) Systems
• Other Products

Modalities Covered:

• Multimodal
• Digital Mammography
• Other Modalities

Applications Covered:

• Advanced Imaging
• Diagnostic Screening
• Other Applications

End Users Covered:

• Breast Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 3032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Mammography Workstation Market, By Product

• 5.1 Introduction
• 5.2 Standalone Workstations
• 5.3 Integrated Workstations
• 5.4 Computer-Aided Detection (CAD) Systems
• 5.5 Other Products

6 Global Mammography Workstation Market, By Modality

• 6.1 Introduction
• 6.2 Multimodal
• 6.3 Digital Mammography
• 6.4 Other Modalities

7 Global Mammography Workstation Market, By Application

• 7.1 Introduction
• 7.2 Advanced Imaging
• 7.3 Diagnostic Screening
• 7.4 Other Applications

8 Global Mammography Workstation Market, By End User

• 8.1 Introduction
• 8.2 Breast Care Centers
• 8.3 Hospitals
• 8.4 Other End Users

9 Global Mammography Workstation Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Agfa-Gevaert NV
• 11.2 Analogic Corporation
• 11.3 Delphinus Medical Technologies, Inc
• 11.4 GE Healthcare
• 11.5 Hologic
• 11.6 Konica Minolta Business Solutions India Private Limited
• 11.7 Medtronic
• 11.8 Micrima Limited
• 11.9 Philips Healthcare
• 11.10 Planmed Oy
• 11.11 Siemens Healthcare